Home › Mutual Funds › Tata Mutual Fund › Tata India Pharma & Healthcare Fund Direct Growth
Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Direct Growth

Add To Compare

36.778 (-1.700%)
NAV on May 29, 2026
Category Equity:
Sector - Healthcare
Investment StyleBox
Mid Growth
Total Assets 1,325 cr
Turnover Ratio 11.18%
Expense Ratio 0.67%
Exit Load 0.25%if redeemed within
30 Days0.00%if redeemed after 30 Days
Returns
  • 1M: 4.24%
  • 1Y: 8.10%
  • 3M: 4.37%
  • 3Y: 24.68%
  • 6M: 1.78%
  • 5Y: 15.33%
Min Investment 5,000
Buy Now Start SIP
ADDITIONAL INFO
Fund Manager Rajat Srivastava (Since over 1 year)
ISIN INF277K019A3
Fund Family Tata
P/E Ratio 40.06
P/B Ratio 6.30
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha 0.68
Beta 0.98
R-Squared 93.48
Info Ratio 0.08
Tracking Err 4.37
Sortino 1.707
Sharpe 0.978
Std Dev 17.082
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.68%
Industrial 0.0%
Technology 0.0%
Basic Materials 5.21%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 94.12%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

You will not receive any dividends. Your investments will get the largest benefit of compounding.

View Factsheet
-


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata

Data Partner
Click here to visit AMC website and
read all scheme related documents Tata Fund